Variant report
Variant | nsv963605 |
---|---|
Chromosome Location | chr4:69083609-69086551 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:8)
- CpG islands (count:122)
- Chromatin interactive region (count:2)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:8 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr4:69086517-69086666 | K562 | blood: | n/a | n/a |
2 | FOS | chr4:69083875-69084084 | MCF10A-Er-Src | breast: | n/a | chr4:69083968-69083979 chr4:69083954-69083962 chr4:69083952-69083964 |
3 | FOS | chr4:69083799-69084110 | MCF10A-Er-Src | breast: | n/a | chr4:69083968-69083979 chr4:69083954-69083962 chr4:69083952-69083964 |
4 | FOS | chr4:69083797-69084101 | MCF10A-Er-Src | breast: | n/a | chr4:69083968-69083979 chr4:69083954-69083962 chr4:69083952-69083964 |
5 | FOS | chr4:69083789-69084101 | MCF10A-Er-Src | breast: | n/a | chr4:69083968-69083979 chr4:69083954-69083962 chr4:69083952-69083964 |
6 | GTF2F1 | chr4:69084062-69084217 | H1-hESC | embryonic stem cell: | n/a | n/a |
7 | JUND | chr4:69086518-69086793 | HepG2 | liver: | n/a | n/a |
8 | POLR2A | chr4:69085264-69085321 | MCF10A-Er-Src | breast: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:69084723-69084773 | T-47D | breast: | n/a |
2 | chr4:69083729-69083779 | HEK293 | kidney: | embryo |
3 | chr4:69083729-69083779 | GM12878 | blood: | n/a |
4 | chr4:69084723-69084773 | HCPEpiC | choroid plexus: | n/a |
5 | chr4:69083729-69083779 | HCF | heart: | n/a |
6 | chr4:69084723-69084773 | IMR90 | lung: | fetal |
7 | chr4:69084723-69084773 | BE2_C | brain: | n/a |
8 | chr4:69083729-69083779 | Hepatocyte | liver: | n/a |
9 | chr4:69083729-69083779 | HNPCEpiC | eye: | n/a |
10 | chr4:69084723-69084773 | CMK | blood: | n/a |
11 | chr4:69084723-69084773 | NB4 | blood: | n/a |
12 | chr4:69083729-69083779 | H1-hESC | embryonic stem cell: | embryo |
13 | chr4:69083729-69083779 | HRPEpiC | eye: | n/a |
14 | chr4:69083729-69083779 | HEEpiC | esophagus: | n/a |
15 | chr4:69083729-69083779 | HRCEpiC | kidney: | n/a |
16 | chr4:69083729-69083779 | HIPEpiC | eye: | n/a |
17 | chr4:69083729-69083779 | SK-N-MC | brain: | n/a |
18 | chr4:69084723-69084773 | HPAEpiC | pulmonary alveolar: | n/a |
19 | chr4:69084723-69084773 | AG04450 | lung: | fetal |
20 | chr4:69084723-69084773 | GM12878 | blood: | n/a |
21 | chr4:69084723-69084773 | Jurkat | blood: | n/a |
22 | chr4:69084723-69084773 | K562 | blood: | n/a |
23 | chr4:69083729-69083779 | HMEC | breast: | n/a |
24 | chr4:69084723-69084773 | PFSK-1 | brain: | n/a |
25 | chr4:69083729-69083779 | LNCaP | prostate: | n/a |
26 | chr4:69083729-69083779 | HUVEC | blood vessel: | n/a |
27 | chr4:69084723-69084773 | BJ | skin: | n/a |
28 | chr4:69084723-69084773 | ProgFib | skin: | n/a |
29 | chr4:69083729-69083779 | HPAEpiC | pulmonary alveolar: | n/a |
30 | chr4:69083729-69083779 | GM12892 | blood: | n/a |
31 | chr4:69084723-69084773 | NHBE | bronchial: | n/a |
32 | chr4:69084723-69084773 | HAEpiC | amniotic membrane: | n/a |
33 | chr4:69083729-69083779 | AoSMC | blood vessel: | n/a |
34 | chr4:69084723-69084773 | PrEC | prostate: | n/a |
35 | chr4:69084723-69084773 | SK-N-MC | brain: | n/a |
36 | chr4:69084723-69084773 | AG10803 | skin: | n/a |
37 | chr4:69084723-69084773 | PANC-1 | pancreas: | n/a |
38 | chr4:69083729-69083779 | NHBE | bronchial: | n/a |
39 | chr4:69084723-69084773 | SKMC | muscle: | n/a |
40 | chr4:69084723-69084773 | HMEC | breast: | n/a |
41 | chr4:69083729-69083779 | A549 | lung: | n/a |
42 | chr4:69083729-69083779 | HL-60 | blood: | n/a |
43 | chr4:69083729-69083779 | NT2-D1 | testis: | n/a |
44 | chr4:69083729-69083779 | PANC-1 | pancreas: | n/a |
45 | chr4:69084723-69084773 | AG09319 | gingival: | n/a |
46 | chr4:69083729-69083779 | AG09309 | skin: | n/a |
47 | chr4:69083729-69083779 | Jurkat | blood: | n/a |
48 | chr4:69084723-69084773 | SK-N-SH_RA | brain: | n/a |
49 | chr4:69084723-69084773 | HCF | heart: | n/a |
50 | chr4:69083729-69083779 | HAEpiC | amniotic membrane: | n/a |
(count:2 , 50 per page) page:
1
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-TMPRSS11BNL-1 | chr4:69083624-69083721 | NONHSAT096727 |
2 | lnc-TMPRSS11BNL-1 | chr4:69083624-69083722 | NONHSAT096726 |
No data |
No data |
Variant related genes | Relation type |
---|---|
TMPRSS11BNL | TF binding region |
ENSG00000250026 | TF binding region |
TMPRSS11BNL | CpG island |
ENSG00000250026 | CpG island |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs142904566 | chr4:69083634-69083635 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs551550752 | chr4:69083656-69083657 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs571345763 | chr4:69083665-69083666 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs535460243 | chr4:69083674-69083675 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs533588883 | chr4:69083702-69083703 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs576569159 | chr4:69083723-69083724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs34260584 | chr4:69083864-69083865 | Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs34548520 | chr4:69083869-69083870 | Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs544379426 | chr4:69083871-69083872 | Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs397720851 | chr4:69083877-69083878 | Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs201299317 | chr4:69083878-69083879 | Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs199658820 | chr4:69083879-69083880 | Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs151097646 | chr4:69083886-69083887 | Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs567101798 | chr4:69083897-69083898 | Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs75176935 | chr4:69083927-69083928 | Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs12512581 | chr4:69083953-69083954 | Enhancers | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs539727826 | chr4:69083963-69083964 | Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs11447187 | chr4:69084008-69084009 | Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs397792446 | chr4:69084010-69084011 | Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs139543060 | chr4:69084085-69084086 | Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs538424606 | chr4:69084102-69084103 | Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs75942551 | chr4:69084118-69084119 | Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs145174664 | chr4:69084178-69084179 | Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs190890629 | chr4:69084724-69084725 | Inactive region | CpG island | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs549689898 | chr4:69084728-69084729 | Inactive region | CpG island | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs376174880 | chr4:69085265-69085266 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs11735405 | chr4:69085306-69085307 | Inactive region | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Osteoporosis | 18992858 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Graft versus host disease | 20877625 | CNVD |
Breast cancer | 21990379 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Osteoporosis | 20877625 | CNVD |
Osteoporosis | 19737800 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Oral cancer | 21386901 | CNVD |
Alcoholism | 21790672 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Recurrent pregnancy loss | 19789632 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Schizophrenia | 20967226 | CNVD |
Autism | 19287141 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Ollier disease | 21235737 | CNVD |
Autism | 21865298 | CNVD |
Rett syndrome | 21593744 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Incontinentia Pigmenti | 22033527 | CNVD |
Oligozoospermia | 20877625 | CNVD |
Sertoli-cell only syndrome | 20877625 | CNVD |
Thoracic aortic aneurysm | 21698135 | CNVD |
Breast cancer | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:69080400-69084200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr4:69082000-69083800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
3 | chr4:69082000-69084200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr4:69082200-69084200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr4:69083000-69083800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
6 | chr4:69083200-69084000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
7 | chr4:69083400-69084200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |